First Trust NYSE Arca Biotechnology Index Fund (FBT): ETF
ETF traded on ARCX under symbol FBT. Quoted in usd.
First Trust NYSE Arca Biotechnology Index Fund
+0.83%$273.73
ARCX:FBTSector Equity
AUM $3B·YTD --·Yield --
ARCX:FBT$273.73+0.83%AUM $3BAbout FBT
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
Largest holdings
- GMAB Genmab A/S (ADR)3.93%
- HALO Halozyme Therapeutics, Inc.3.78%
- BIIB Biogen Inc.3.65%
- ALKS Alkermes Plc3.57%
- EXEL Exelixis, Inc.3.55%
- REGN Regeneron Pharmaceuticals, Inc.3.53%
- UTHR United Therapeutics Corporation3.52%
- AMGN Amgen Inc.3.50%
- ADMA ADMA Biologics, Inc.3.49%
- VCYT Veracyte, Inc.3.48%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$109,735
Total Return
+$39,735
(+56.8%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$3.00B
NAV$271.38
Premium/Discount+0.87%
Expense Ratio0.55%
Market Cap--
Shares Outstanding--
Inception DateJun. 19, 2006
Fund Details
IssuerFirst Trust
Asset ClassSector Equity
Beta--
SectorFinancial Services
DomicileUS
52-Week Range
$186.20$275.23
Current: $273.73
Volume
Volume47.61K
Avg Volume77.27K
Vol/Avg0.62x
30d
64.58K
60d
68.89K
90d
61.01K
Comparable ETFs